Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibrosis | stella

Learn About Find trials matched to me

About Learn Find trials matched to me →

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Privacy ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibrosis | stella

Back to Interstitial Lung Disease trials

Recruiting

Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.

Trial locations(1 site)

United States

Massachusetts General Hospital, Boston, Massachusetts

Key details

Phase

Testing effectiveness

Sponsor

Peter Caravan

Collaborators

National Heart, Lung, and Blood Institute (NHLBI)

Enrollment target

~15 participants

Started

April 2026

Primary completion

December 2028

View full record on ClinicalTrials.gov

Age range

18 Years – 80 Years

Last updated on clinicaltrials.gov in May 2026.

Contact the research team directly

Reach out to the team running this trial. Response times vary — some teams are faster than others.

Central contact

Sydney Montesi, MD

Massachusetts General Hospital

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Enrollment status is pulled from ClinicalTrials.gov and may not reflect real-time availability. If a trial appears full when you reach out, the team will let you know.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.